Biotechnology: An Industry Comes of Age
Based on a conference held in Washington, D.C., Feb. 27-28, 1985, and sponsored by the Academy Industry Program of the National Academy of Sciences, National Academy of Engineering, and Institute of Medicine.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
agriculture Alexander amino acids approval Asilomar bacteria bacterium basic biotechnol biotechnology firms biotechnology industry bone marrow cells Centocor chapter includes material chemical commercial committee companies crops disease effect environment environmental release enzymes established experience fermentation field test funds genetic material genetically engineered microorganisms genetically engineered organisms germline germline gene therapy growth hormone guidelines human cells human gene therapy hybridoma immune infect inserted instance institutions introduced investments involved issues Japan Japanese government Jaworski Kipnis laboratory manufacturer microbes molecular molecules monoclonal antibodies Monsanto National Academy nitrogen patent application patent system pesticides pharmaceuticals Philip Leder plant cells plasmids possible potential problems products of biotechnology Protection proteins protoplasts recombinant DNA regulation of biotechnology regulatory require retroviruses risk Rubisco Saliwanchik Saxonhouse says Science scientific scientists somatic cell specific start-up substances techniques toxic trade secret transfer U.S. Department United universities university-industry vaccines Washington